Review of vascularized bone marrow transplantation: Current status and future clinical applications
In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment...
Saved in:
Published in | Microsurgery Vol. 27; no. 4; pp. 348 - 353 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment period, provides critical signaling and modulatory functions, and may potentiate tolerance induction. Thus far, VBMT studies have demonstrated an absence of graft‐versus‐host disease (GVHD) and robust engraftment into nonmanipulated as well as irradiated recipients with evidence of immunological tolerance. Further investigation is needed to determine the applicability of VBMT as an alternative to BMT. © 2007 Wiley‐Liss, Inc. Microsurgery 2007. |
---|---|
Bibliography: | istex:C7D88D18A469A680D923D4BB8489A9726FA1846F American Heart Association (Heritage Affiliate Grant) - No. 0555795T ark:/67375/WNG-D0N35DVW-T ArticleID:MICR20367 Dr. Hewitt is the American Heart Association Ellen Marmer Research Fellow. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0738-1085 1098-2752 |
DOI: | 10.1002/micr.20367 |